In Regard to Mattonen et al

doi:10.1016/j.ijrobp.2016.03.038

Comment

. 2016 Aug 1;95(5):1544-1545.

doi: 10.1016/j.ijrobp.2016.03.038.

In Regard to Mattonen et al

Roger Sun¹, Fanny Orlhac², Charlotte Robert³, Sylvain Reuzé³, Antoine Schernberg¹, Irène Buvat², Eric Deutsch⁴, Charles Ferté⁵

Affiliations

¹ Radiation Oncology Department, Gustave Roussy Cancer Campus, Paris-Sud University, Villejuif, France.
² Imagerie Moléculaire In Vivo, Commissariat à l'énergie atomique et aux énergies alternatives, Institut national de la santé et de la recherche médicale, Centre national de la recherche scientifique, Paris-Sud University, Commissariat à l'énergie atomique et aux énergies alternatives-Service Hospitalier Frédéric Joliot, Orsay, France.
³ INSERM U1030 Molecular Radiotherapy, Gustave Roussy Cancer Campus, Paris-Sud University, Villejuif, France.
⁴ Radiation Oncology Department and INSERM U1030 Molecular Radiotherapy, Gustave Roussy Cancer Campus, Paris-Sud University, Villejuif, France.
⁵ INSERM U1030 Molecular Radiotherapy and Department of Head and Neck Cancer Oncology, Gustave Roussy Cancer Campus, Paris-Sud University, Villejuif, France.

PMID: 27479727
DOI: 10.1016/j.ijrobp.2016.03.038

Comment

In Regard to Mattonen et al

Roger Sun et al. Int J Radiat Oncol Biol Phys. 2016.

. 2016 Aug 1;95(5):1544-1545.

doi: 10.1016/j.ijrobp.2016.03.038.

Authors

Roger Sun¹, Fanny Orlhac², Charlotte Robert³, Sylvain Reuzé³, Antoine Schernberg¹, Irène Buvat², Eric Deutsch⁴, Charles Ferté⁵

Affiliations

¹ Radiation Oncology Department, Gustave Roussy Cancer Campus, Paris-Sud University, Villejuif, France.
² Imagerie Moléculaire In Vivo, Commissariat à l'énergie atomique et aux énergies alternatives, Institut national de la santé et de la recherche médicale, Centre national de la recherche scientifique, Paris-Sud University, Commissariat à l'énergie atomique et aux énergies alternatives-Service Hospitalier Frédéric Joliot, Orsay, France.
³ INSERM U1030 Molecular Radiotherapy, Gustave Roussy Cancer Campus, Paris-Sud University, Villejuif, France.
⁴ Radiation Oncology Department and INSERM U1030 Molecular Radiotherapy, Gustave Roussy Cancer Campus, Paris-Sud University, Villejuif, France.
⁵ INSERM U1030 Molecular Radiotherapy and Department of Head and Neck Cancer Oncology, Gustave Roussy Cancer Campus, Paris-Sud University, Villejuif, France.

PMID: 27479727
DOI: 10.1016/j.ijrobp.2016.03.038

No abstract available

PubMed Disclaimer

Comment in

In Reply to Sun et al.
Mattonen SA, Ward AD, Palma DA. Mattonen SA, et al. Int J Radiat Oncol Biol Phys. 2016 Aug 1;95(5):1545-1546. doi: 10.1016/j.ijrobp.2016.03.039. Int J Radiat Oncol Biol Phys. 2016. PMID: 27479728 No abstract available.

Comment on

Detection of Local Cancer Recurrence After Stereotactic Ablative Radiation Therapy for Lung Cancer: Physician Performance Versus Radiomic Assessment.
Mattonen SA, Palma DA, Johnson C, Louie AV, Landis M, Rodrigues G, Chan I, Etemad-Rezai R, Yeung TP, Senan S, Ward AD. Mattonen SA, et al. Int J Radiat Oncol Biol Phys. 2016 Apr 1;94(5):1121-8. doi: 10.1016/j.ijrobp.2015.12.369. Epub 2015 Dec 29. Int J Radiat Oncol Biol Phys. 2016. PMID: 26907916

Cited by

Advances in artificial intelligence for the diagnosis and treatment of ovarian cancer (Review).
Wang Y, Lin W, Zhuang X, Wang X, He Y, Li L, Lyu G. Wang Y, et al. Oncol Rep. 2024 Mar;51(3):46. doi: 10.3892/or.2024.8705. Epub 2024 Jan 19. Oncol Rep. 2024. PMID: 38240090 Free PMC article. Review.
Integrating Radiogenomics and Machine Learning in Musculoskeletal Oncology Care.
Kumar R, Sporn K, Khanna A, Paladugu P, Gowda C, Ngo A, Jagadeesan R, Zaman N, Tavakkoli A. Kumar R, et al. Diagnostics (Basel). 2025 May 29;15(11):1377. doi: 10.3390/diagnostics15111377. Diagnostics (Basel). 2025. PMID: 40506947 Free PMC article. Review.
Influence of Magnetic Field Strength on Magnetic Resonance Imaging Radiomics Features in Brain Imaging, an In Vitro and In Vivo Study.
Ammari S, Pitre-Champagnat S, Dercle L, Chouzenoux E, Moalla S, Reuze S, Talbot H, Mokoyoko T, Hadchiti J, Diffetocq S, Volk A, El Haik M, Lakiss S, Balleyguier C, Lassau N, Bidault F. Ammari S, et al. Front Oncol. 2021 Jan 20;10:541663. doi: 10.3389/fonc.2020.541663. eCollection 2020. Front Oncol. 2021. PMID: 33552944 Free PMC article.
Potential advantages of FDG-PET radiomic feature map for target volume delineation in lung cancer radiotherapy.
Falahatpour Z, Geramifar P, Mahdavi SR, Abdollahi H, Salimi Y, Nikoofar A, Ay MR. Falahatpour Z, et al. J Appl Clin Med Phys. 2022 Sep;23(9):e13696. doi: 10.1002/acm2.13696. Epub 2022 Jun 14. J Appl Clin Med Phys. 2022. PMID: 35699200 Free PMC article.
Prediction of cervical cancer recurrence using textural features extracted from 18F-FDG PET images acquired with different scanners.
Reuzé S, Orlhac F, Chargari C, Nioche C, Limkin E, Riet F, Escande A, Haie-Meder C, Dercle L, Gouy S, Buvat I, Deutsch E, Robert C. Reuzé S, et al. Oncotarget. 2017 Jun 27;8(26):43169-43179. doi: 10.18632/oncotarget.17856. Oncotarget. 2017. PMID: 28574816 Free PMC article.

See all "Cited by" articles

Publication types

Actions
Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science
Other Literature Sources
- The Lens - Patent Citations Database
- scite Smart Citations

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

In Regard to Mattonen et al

Affiliations

In Regard to Mattonen et al

Authors

Affiliations

Comment in

Comment on

Similar articles

Cited by

Publication types

LinkOut - more resources

Full Text Sources

Other Literature Sources